| ²é¿´: 2575 | »Ø¸´: 14 | |||||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||||
[½»Á÷]
ʵÓÃÒ©¼Á´Ê»ã
|
|||||
|
1-NEP N-ÒÒ»ùßÁ¿©Íª 1-NMP N-¼×»ùßÁ¿©Íª 2G-¦Â-CYD ¶þÆÏÌÇ»ù£¡¡£»·ºý¾« 2-HP-¦Â-CYD 2£ôDZû»ù£¡¡£»·ºý¾« 5-NCP 5-ôÈ»ùßÁ¿©Íª 5-NMP 5-¼×»ùßÁ¿©Íª Accelerated testing ¼ÓËÙÊÔÑé Acrylic acid resin ±ûÏ©ËáÊ÷õ¥ Active targeting preparation Ö÷¶¯°ÐÏòÖÆ¼Á Adersive dispersion-type TTS Õ³½º·ÖÉ¢ÐÍTTS Adhersive strength Õ³¸½Á¦ Adhesion Õ³¸½ÐÔ Adhesives Õ³ºÏ¼Á Aerosil ΢·Û¹è½º Aerosol ÆøÎí¼Á Aerosol of micropowders for inspiration ÎüÈë·ÛÎí¼Á Aethylis oleas ÓÍËáÒÒõ¥ Agglomerate ¾Û½áÎï Aggregation ¾Û¼¯ Air suspension ¿ÕÆøÐü¸¡·¨ Alarm clock ÄÖÖÓ Alcohol ÒÒ´¼ All-trans È«·´Ê½ Alterntae addition method Á½Ïà½»Ìæ¼ÓÈë·¨ Amebocyte lysate ±äÐÎϸ°ûÈܽâÎï Amorphous forms ÎÞ¶¨ÐÍ Angle of repose ÐÝÖ¹½Ç Antiadherent ¿¹Õ³¼Á Antioxidants ¿¹Ñõ¼Á Antisepesis ·À¸¯ Apparent solubility ±íÏÖÈܽâ¶È Aprotinin ÒÖ̪ø Aquacoat ÒÒ»ùÏËÎ¬ËØË®·ÖÉ¢Ìå Aromatic waters ·¼ÏãË®¼Á Arrhenius ·½³Ì °¢ÂØÄáÎÚ˹·½³Ì Ascabin ±½¼×Ëá¡¡õ¥ Aseptic technique ÎÞ¾ú²Ù×÷·¨ Azone µªÍª Azone µªÍª Ball mill ÇòÄ¥»ú Base adsorption »ùÖÊÎü¸½ÂÊ Bases »ùÖÊ Beeswax ·äÀ¯ Bending ÍäÇúÁ¦ BHA Êå¶¡»ù¶ÔôÇ»ùÜîÏãÃÑ BHT ¶þÊå¶¡»ù¶Ô¼×·Ó Bioavailability ÉúÎïÀûÓÃ¶È Biochemical approach ÉúÎïѧ·½·¨ Biopharmaceutics ÉúÎïÒ©¼Áѧ Biotechnology ÉúÎï¼¼Êõ Bondѧ˵ ÖеȷÛË飨Á£¾¶£© Bound water ½áºÏË®·Ö Breakage (Bk) ´àËé¶È Brij ¡¡Ôó¡¢¾ÛÑõÒÒϩ֬·¾´¼ÃÑ Brij ¾ÛÑõÒÒϩ֬·¾´¼ÃÑ Buccal tablets ¼Õ¶îƬ Bulk density ËÉÃÜ¶È Bulk density ËÉÃܶȡ¢¶ÑÃÜ¶È Burst effect Í»ÊÍЧӦ CA ´×ËáÏËÎ¬ËØ CAB ´×ËáÏËÎ¬ËØ¶¡Ëáõ¥ Cabomer ôÇ»ùÒÒÏ©¹²¾ÛÎï Caking ½á±ý CAP ´×ËáÏËÎ¬ËØÌªËáõ¥ CAP ÁÚ±½¶þ¼×Ëá´×ËáÏËÎ¬ËØ CAP ÁÚ±½¶þ¼×Ëá´×ËáÏËÎ¬ËØ CAP ÁÚ±½¶þ¼×Ëá´×ËáÏËÎ¬ËØ CAP ÁÚ±½¶þ¼×Ëá´×ËáÏËÎ¬ËØ Capillary state ëϸ¹Ü×´ Capsules ½ºÄÒ¼Á Carbomer ¿¨²¨Ä·¡¢ôÈ»ùÒÒÏ©¹²¾ÛÎï Carbopol ¿¨²¨ÆÕ Carbopol 934 ¿¨²¨ÆÕ Carboxymethyl cellulose sodium ôǼ׻ùÏËÎ¬ËØÄÆ Carboxymethyl starch sodium CMS-Naôȼ׻ùµí·ÛÄÉ Carboxymethylcellulose sodium CMC-Naôȼ׻ùÏËÎ¬ËØÄÉ CAT ´×ËáÏËÎ¬ËØ±½ÈýËáõ¥ CD Ô²¶þÉ«Æ×·¨ Cellulose acetate (CA) ´×ËáÏËÎ¬ËØ Cellulose acetate phthalate (CAP) ´×ËáÏËÎ¬ËØÌªËá´× Central composite design (CCD) ÐǵãÉè¼Æ Cera aseptical pro osse bone wax ¹ÇÀ¯ Ceramide Éñ¾õ£°· Cetomacrogol ¾ÛÒÒ¶þ´¼ÓëÊ®Áù´¼ËõºÏ Chemical approach »¯Ñ§·½·¨ Chewable tablets ¾×½ÀƬ Chitin ¿Ç¶àÌÇ Chitosan ¿Ç¾ÛÌÇ Chronopathology ʱ³½²¡Àíѧ Chronopharmacology ʱ³½Ò©Àíѧ Clausius-Clapeyron·½³Ì ¿ËÀÍÐÞ˹£¿ËÀçêÁú·½³Ì Clinical pharmaceutics ÁÙ´²Ò©¼Áѧ Cloud point ¶Ô¾ÛÑõÒÒÏ©ÐÍ·ÇÀë×Ó±íÃæ»îÐÔ¼Á CMC-Na ôȼ׻ùÏËÎ¬ËØÄÉ CMC-Na ôȼ׻ùÏËÎ¬ËØÄÉ CMC-Na ôǼ׻ùÏËÎ¬ËØ CMEC ôȼ×ÒÒÏËÎ¬ËØ CMS ôȼ׻ùµí·Û CMS-Na ôȼ׻ùµí·ÛÄÆ Coadminiatration of skin Meta Inh Ƥ·ô´úлÒÖÖÆ¼ÁµÄºÏÓà Coadministraition of chem. P Enh »¯Ñ§ÎüÊÕ´Ù½ø¼ÁµÄºÏÓà Coagulation ¾Û³Á Coated tablets °üÒÂÆ¬ Coating material ±í²Ä Cocoa butter ¿É¿É¶¹Ö¬ Cohesion Äý¾ÛÐÔ¡¢Õ³×ÅÐÔ Cohesive strength ÄÚ¾ÛÁ¦ Cold compression method Æûѹ·¨ Cold-homogenization ÀäÈ´Ò»ÔÈ»¯·¨ Colon-targeted capsules ½á³¦°ÐÏò½ºÄÒ¼Á Compactibility ³ÉÐÎÐÔ Complex coacervation ¸´Äý¾Û·¨ Compliance ˳ӦÐÔ Compliance ˳ӦÐÔ Compressed tablets ÆÕͨƬ Compressibility ѹËõ¶È Compressibility ѹËõÐÔ Compression ѹËõÁ¦ Compressive work ѹËõ¹¦ Cone and plate viscometer Բ׵ƽ°åÕ³¶È¼Æ Consistency curve ³í¶ÈÇúÏß Controllability ¿É¿ØÐÔ Controlled release tablets ¿ØÊÍÆ¬ Controlled-release preparation ¿ØÊÍÖÆ¼Á Convective mixing ¶ÔÁ÷»ìºÏ Convective transport ´«µÝ͸¹ý Coordination number ÅäλÊý Copoly (latic/glycolic) acid ¾ÛÈéËáÒÒ´¼Ëá¹²¾ÛÎï Core material ±íÐÄÎï Cosolvency DZÈÜ Cosolvency DZÈÜ Cosolvent DZÈܼÁ Cosolvent DZÈܼÁ Coulter counter method ¿â¶ûÌØ¼ÆÊý·¨ Count basis ¸öÊý»ù×¼ CP ¾ÛôÈÒÒÏ© CPVP ½»Áª¾ÛÒÒÏ©±È¿©Íéͪ CRacemization ÍâÏûÐý×÷Óà Creams ÈéÇà¼Á Creep Èä±äÐÔ Cremolphore EL ¾ÛÑõÒÒÏ©±ÍÂéÓ͸ÊÓÍÃÑ Critical relative humidity (CRH) ÁÙ½çÏà¶Ôʪ¶È Critical relative humidity£¨CRH£© ÁÙ½çÏà¶Ôʪ¶È Critical velocity ÁÙ½çËÙ¶È Critrical micell concentration CMCÁÙ½ç½ºÊøÅ¨¶È Croscarmellose sodium CCNa½»Áªôȼ׻ùÏËÎ¬ËØÄÉ Croscarmellose sodium (CCNa) ½»Áª¼×»ùÏËÎ¬ËØÄÆ Crospovidone ½»Áª¾Ûάͪ Cross-liked polyvinyl pyrrolidone PVPP½»Áª¾Ûάͪ Crushing ·ÛËé Crystal form ¾§ÐÍ Crystal habit ¾§Ì¬¡¢¾§ñ±¡¢½á¾§Ï°ÐÔ CTS ÆÕͨ˨¼Á Cumulative size distribution ÀÛ»ý·Ö²¼ Cutting ¼ôÇÐÁ¦ Cyclodextrin (CYD) »·ºý¾« Cylinder model Բ˨ÌåÄ£ÐÍ Cytotoxicity ϸ°ûËØ DDS Ò©Îï´«µÝϵͳ Decoction ÌÀ¼Á Degree of circularity Ô²ÐÎ¶È Degree of sphericility ÇòÐÎ¶È Delipidization ½ÇÖʲãÈ¥Ö¬ÖÊ»¯ Dextrin ºý¾« Dialysis cell method ÉøÎö³Ø·¨ Dicetyl phosphate Á×Ëá¶þ¾¨À¯Ö¬ Dielectric constant ½éµç³£Êý Differential scanning calorimetry DSC²îʾɨÃèÏÔÈÈ·¨ Differential thermal analysis DTA²îʾÈÈ·ÖÎö·¨ Diffusive mixing À©É¢»ìºÏ Dilatant flow ÕÍÐÔÁ÷¶¯ Diluents Ï¡ÊͼÁ¡¢Ìî³ä¼Á Dimethicone (silicones) ¶þ¼×»ù¹èÓÍ¡¢¹èÓÍ¡¢¹èͪ Dimethyl sulfoxide(DMSO) ¶þ¼×»ùÑÇí¿ Dimethylacetamide (DMA) ¶þ¼×»ùÒÒõ£°· Disinfection Ïû¶¾ Disintegrants ±À½â¼Á Disk assemble method Ô²ÅÌ·¨ Disperse medium ·ÖÉ¢½éÖÊ Disperse phase ·ÖÉ¢Ïà Disperse system ·ÖÉ¢Ìåϵ Dispersed phase ·ÖÉ¢Ïà¡¢ÄÚÏà¡¢·ÇÁ¬ÐøÏà Dispersible tablets ·ÖɢƬ Displacement value (DV) Öû»¼Û Distilled water ÕôÁóË® DL-phenylalanine ethyl acetoacetate DL±½»ù±½°·ÒÒÃÑÒÒËáÒÒõ¥ DLVOÀíÂÛ ÒýÁ¦ÊÆÄÜÓë³âÁ¦ÊÆÄÜ DME ¶þ¼×ÃÑ DMSO ¶þ¼×»ùÑÇ·¯ DM-¦Â-CYD ¶þ¼×»ù£¡¡£»·ºý¾« Donor cell ¹©¸ø±¦ DOPE ¶þÓÍõ£Á×Ö¬õ£ÒÒ´¼°· DOPE ¶þÓÍõ£Á×Ö¬õ£ÒÒ´¼°· Dosage form Ò©Îï¼ÁÐÍ DPPC ¶þרéµõ£Á×Ö¬õ£µ¨¼î DPPC ¶þרéµõ£Á×Ö¬õ£µ¨¼î Drop dentifrices µÎÑÀ¼Á Drug carrier Ò©ÎïÔØÌå Drug-loading rate ÔØÒ©Á¿ Dry bulb temperature ¸ÉÇòÎÂ¶È DSPC ¶þÓ²Ö¬õ£Á×Ö¬õ£µ¨¼î DSPE ¶þÓ²Ö¬õ£Á×Ö¬õ£ÒÒ´¼°· Dumping effect Í»ÊÍЧӦ EA ÒÒ»ùÏËÎ¬ËØ Ear drops µÎ¶ú¼Á EC ÒÒ»ùÏËÎ¬ËØ EC ëϸ¹ÜµçÓ¾ EC ÒÒ»ùÏËÎ¬ËØ Effect diameter Dsk,ÓÐЧ¾¶ Effectiveness ÓÐЧÐÔ Effervescent disintegrants ÅÝÌÚ±À½â¼Á Effervescent tablets ÅÝÌÚÆ¬ Elastic deformation µ¯ÐÔ±äÐÎ Elastic recovery (ER) µ¯ÐÔ¸´ÔÂÊ Elastic work µ¯ÐÔ¹¦ Elasticity µ¯ÐÔ Electro phoresis µçÓ¾ Electroporesis µçÖ¿׷¨ Electuary ¼å¸à¼Á EMA ¼×±ûÏ©ËáÒÒõ¥ Emolphor ¾ÛÑõÒÒÏ©±ÍÂéÓÍ»¯ºÏÎï Emulsifer in water method Ë®ÖÐÈ黯¼Á·¨¡¢Êª½º·¨ Emulsifier in oil method ÓÍÖÐÈ黯¼Á·¨¡¢¸É½º·¨ Emulsion ÆÕͨÈé Emulsions Èé¼Á Enamine Ï©°· Endocytosis ÄÚ…× Endotoxin ÄÚ¶¾ËØ Enteric capsules ³¦ÈܽºÄÒ¼Á Enteric coated tablets ³¦ÈÜÒÂÆ¬ Entrapment rate °ü·âÂÊ Epidermis ±íƤ Epimerization ²îÏòÒì¹¹×÷Óà EPRЧӦ ´ÙÉøÖÍÁô×÷Óà Equilibrium solubility ƽºâÈܽâ¶È Equilibrium water ƽºâË®·Ö Equivalent specific surface DSV¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡ Equivalent volume diameter Dv£¬Ìå»ýµÈ¼Û¾¶£¬ÇòÏ൱¾¶ Ethanol ÒÒ´¼ Ethical (prescription) drug ´¦·½Ò© Ethycellulose (EC) ÒÒ»ùÏËÎ¬ËØ Ethylcellulose ECÒÒ»ùÏËÎ¬ËØ Ethylene vilnylacetate copolymer ÒÒÏ©-´×ËáÒÒÏ©¹²¾ÛÎï Ethylene vinylacetate copolymer ÒÒÏ©£´×ËáÒÒÏ©¹²¾ÛÎï Eu L, Eu S ¾Û¼×»ù±ûÏ©Ëá Eu RL, Eu RS ¾Û¼×»ù±ûÏ©Ëáõ¥ Eu RL100, Eu RS100 ¼×»ù±ûÏ©Ëáõ¥¹²¾ÛÎ²»ÈÜ£© Eu RL100, Eu SL100 ¾Û±ûÏ©ËáÊ÷֬ϵÁÐ Eu S100, Eu L100 ¼×»ù±ûÏ©Ëá¹²¾ÛÎ³¦ÈÜ£© Eudragit (E, RL, RS) ¼×»ù±ûÏ©Ëáõ¥¹²¾ÛÎï Eudragit L100 ¼×»ù±ûÏ©Ëá¹²¾ÛÎï Eudragit RS100, RL100, NE30D ¼×»ù±ûÏ©ËáËá¹²¾ÛÎï- Eudragit S100 ¼×»ù±ûÏ©Ëá¹²¾ÛÎï EVA ÒÒÏ©£´×ËáÒÒÏ©¹²¾ÛÎï Evaporation Õô·¢ Excipients (adjuvants) ¸¨ÁÏ External phase ·ÖÉ¢½éÖÊ¡¢ÍâÏà¡¢Á¬ÐøÏà Extracts ½þ¸à¼Á Eye drop µÎÑÛ¼Á Eye ointments ÑÛ¸à¼Á Factorial design ÎöÒòÉè¼Æ Fatty oils Ö¬·¾ÓÍ Feret diameter ¶¨·½Ïò½ÓÏß¾¶ FicksµÚÒ»À©É¢¹«Ê½ Ò©²ÄÌáÈ¡ Fillers Ìî³ä¼Á Film coated tablets ±¡Ä¤ÒÂÆ¬ Film dispersion method ±¡·ÖÉ¢·¨ Films Ĥ¼Á First-pass effect Ê×¹ýЧӦ Fliud extracts Á÷½þ¸à¼Á Flocculation ÐõÄý Flocculation ÐõÄý Flocculation value ÐõÄý¶È Flow curve Á÷¶¯ÇúÏß Flow velocity Á÷³öËÙ¶È Flowability Á÷¶¯ÐÔ Fluid-energy mills Á÷ÄÜÄ¥¡¢ÆøÁ÷ʽ·ÛËé»ú Fluidity buffer Á÷¶¯ÐÔ»º³å¼Á Fluidized bed coating Á÷»¯´²°üÒ·¨ Free water ×ÔÓÉË®·Ö Freely movable liquid ×ÔÓÉÁ÷¶¯ÒºÌå Freon ·úÂÈÍéžùÀà¡¢·úÀï°º Frequency size distribution ƵÂÊ·Ö²¼ Funicular state Ë÷´ø×´ Fusion ÈÚºÏ Fusion method ÈÈÀÓ·¨ Garles º¬??¼Á GAS ÆøÌå·´ÈܼÁ¼¼Êõ Gas adsorption method ÆøÌåÎü¸½·¨ Gas antisolution GAS Gas permeability method ÆøÌå͸¹ý·¨ GCP Ò©ÎïÁÙ´²ÊÔÑé¹ÜÀí¹æ·¶ Gelatin ëÖ½º Gelatin Ã÷½º Gelatin glycerin ¸ÊÓÍëÖ½º Gelatinization ºý»¯ General acid-base catalysis ¹ãÒåËá¼î´ß»¯ Geometric diameter ¼¸ºÎѧÁ£×Ó¾¶ Geometric isomerization ¼¸ºÎÒì¹¹ Ghost cell Ӱϸ°û Glidants ÖúÁ÷¼Á GLP Ò©Îï·ÇÁÙ´²Ñо¿¹ÜÀí¹æ·¶ Glycerin ¸ÊÓÍ Glycerins ¸ÊÓͼÁ Glyceryl monostearate Ó²Ö¬Ëá¡¢¸ÊÓÍõ¥ Glycolic acid ôÇ»ùÒÒËá GMP Ò©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶ Granule density ¿ÅÁ£ÃÜ¶È Granules ¿ÅÁ£¼Á Graton-FraserÄ£ÐÍ ¿ÅÁ£µÄÅÅÁÐÄ£ÐÍ Group number HLB»ùÍÅÊý Guest molecules ¿Í·Ö×Ó G-¦Â-CYD ÆÏÌÇ£¡¡£»·ºý¾« Half life °ëË¥ÆÚ Handerson-Hasselbach¹«Ê½ ½âÀë״̬¡¢pkc¡¢phµÄ¹ØÏµ Hard capsules Ó²½ºÄÒ¼Á Hardness Ó²¶È HCO ÇâÒDZÍÂéÓÍ HEC ôÇÒÒ»ùÏËÎ¬ËØ HEMA ¼×»ù±ûÏ©ËáôÇÒÒõ¥ HES ôÇÒÒ»ùµí·Û Heywood diameter Dh£¬Í¶Ó°Ãæ»ýÔ²Ï൱¾¶ Higuchi·½³Ì ¡¡¡¡Ï£¹ÅÆõ·½³Ì Host molecules Ö÷·Ö×Ó HPC ôDZûÏËÎ¬ËØ HPC ôDZûÏËÎ¬ËØ HPMA ôDZû¼×±ûÏ©Ëá¼×õ¥ HPMC ôDZû¼×»ùÏËÎ¬ËØ HPMCAS ´×ËáôDZû¼×ÏËÎ¬ËØçúçêËáõ¥ HPMCP ôDZû¼×»ùÏËÎ¬ËØÌªËáõ¥ HPMCP ôDZû¼×ÏËÎ¬ËØ¡¡Ëáõ¥ HPMCP ôǼ׻ùÏËÎ¬ËØÌªËáõ¥ HPMCP (HP-50, HP-55) ôDZû¼×ÏËά¡¡Ëáõ¥ Humidity ʪ¶È Hydration of stratum corneum ½ÇÖʲãµÄË®»¯×÷Óà Hydrogel Ë®ÐÔÄý½º Hydrophile-lipophile balance Ç×Ë®Ç×ÓÍÆ½ºâÖµ Hydrotropy ÖúÈÜ Hydrotropy agent ÖúÈܼÁ Hydroxypropyl methylcellulose ôDZû¼×ÏËÎ¬ËØ Hydroxypropyl methylcellulose acetate succinate ´×ËáôDZû¼×ÏËÎ¬ËØçúçêËáõ¥ Hydroxypropyl methylcellulose phthalate ôDZû¼×ÏËÎ¬ËØÌªËá´× Hydroxypropylcellulose (HPC) ôDZû»ùÏËÎ¬ËØ Hydroxypropylcellulose (HPC) ôDZûÏËÎ¬ËØ Hydroxypropylmethyl cellulose HPMCôDZû¼×»ùÏËÎ¬ËØ Hygroscopicity ÎüʪÐÔ Hypodermic tablets ƤÏÂ×¢ÉäÓÃÆ¬ ICH ¹ú¼Êе÷»áÒé ICH ¹ú¼Êе÷»áÒé IDDS Ö²Èë¸øÒ©ÏµÍ³ IEC Àë×Ó½»»»É«Æ×·¨ IEF µÈµçµã¾Û½¹ Immobile liquid ²»¿ÉÁ÷¶¯ÒºÌå Impact ³å»÷Á¦ Impact mill ³å»÷ʽ·ÛËé»ú Implant tablets Ö²ÈëÆ¬ Inclusion compound °üº¬Îï Industrial pharmaceutics ¹¤ÒµÒ©¼Áѧ Infusion solution ÊäÒº Injection ×¢ÉäÒº In-liquid drying ÒºÖиÉÔï·¨£¨È黯£ÈܼÁ»Ó·¢·¨£© Interface polycondensation ½çÃæËõ¾Û·¨ intra-arterial route ¶¯ÂöÄÚ×¢Éä Intradermal (ID) route ƤÄÚ×¢Éä Intramuscular (IM) route ¼¡Èâ×¢Éä Intravenous (IV) route ¾²Âö×¢Éä Intrinsic dissolution rate ÌØÐÔÈܳöËÙÂÊ Intrinsic solubility ÌØÐÔÈܽâ¶È Inverse targeting ·´Ïò°ÐÏò Iontophoresis Àë×ÓÉøÍ¸·¨ IR ºìÍâ Isoclectric focusing IEFµÈµçµã¾Û½¹ Isoosmotic solution µÈÉøÈÜÒº Isopropylpalmitate Òì±ûËáרéµõ¥ Isostearylisostearate ÒìÓ²Ö¬ËáÒìÓ²õ¥ Isotonic solution µÈÕÅÈÜÒº Isotonic solution µÈÕÅÈÜÒº Journal of Drug Targeting Ò©Îï°ÐÏòÔÓÖ¾ Kickѧ˵ ´Ö·ÛË飨Ìå»ý£© Krafft point ¶ÔÀë×ÓÐͱíÃæ»îÐÔ¼Á¶øÑÔ Krummbein diameter ¶¨·½Ïò×î´ó¾¶ Lactic acid ÈéËá Lactose ÈéÌÇ Lag time ÖÍÁôʱ¼ä Large unilamellar vesicles ´óµ¥ÊÒÖ¬ÖÊÌå Laurocapam Ô¹𵪲Ýͪ Length basis ³¤¶È»ù×¼ L-HPC µÍÈ¡´úôDZû»ùÏËÎ¬ËØ L-HPC µÍÈ¡´úôDZû»ùÏËÎ¬ËØ Limulus lysate test ö×ÊÔÑé·¨ Liniments ²ë¼Á Liposomes Ö¬ÖÊÌå Liquid immersion method Òº½þ·¨ Liquid injection ÎÞÕëÒºÌå×¢ÉäÆ÷ Liquid paraffin ÒºÌåʯÀ¯ Liquid paraffin ÒºÌåʯ´F Long-circulating liposome ³¤Ñ»·Ö¬ÖÊÌå Long-term testing ³¤ÆÚÊÔÑé Loo-Rigelman·½³Ì Ë«±¦ÑªÒ©Å¨¶È£ÎüÊÕÂÊ»»Ëã Lotions Ï´¼Á Lubricants È󻬼Á Lubricants È󻬼Á LUVs ´óµ¥±¦Ö¬ÖÊÌå |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ÎÄѧÉç¿Æ | ¿ÆÑлù´¡ÖªÊ¶ |
» ²ÂÄãϲ»¶
328Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
331Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏÓ뻯¹¤×¨Ë¶306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ24È˻ظ´
²ÄÁϹ¤³Ìµ÷¼Á
ÒѾÓÐ8È˻ظ´
070300»¯Ñ§279Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸ÉϺ£º£Ñó´óѧ083200ʳƷѧ˶£¬Çóµ÷¼Á£¬½ÓÊÜÆäËûרҵ
ÒѾÓÐ12È˻ظ´
²ÄÁÏר˶µ÷¼Á
ÒѾÓÐ14È˻ظ´
334Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ר˶310Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
|
Martin diameter ????????? Mass basis ??????? Matrix type ????? Matrix-diffusion type TTS ¦È???????TTS Maximum additive concentration MAC?????????? MC ???????? MC ???????? MC ???????? MCC ???????? Mechanical interlocking bonds ??????§Ö??? Medicinal liquor ??? Melt-homogenization ?????????? Membrane wall ?????? Membrane-moderated type TTS ???????TTS Methyl acrylate-methacrylate co ????????-???????? Methylcellulose (MC) ???????? Methylcellulose (MC) ???????? Micellar emulsion ?????? Micelle ???? Microcapsules ??? Microcrystalline cellulose (MCC) ???????? Microcrystalline cellulose (MCC) ???????? Microemulsion ??? Microemulsion ??? Microencapsulation ??????????????? Micromeritics ????? Microreservoir-type TTS ??????? Microscropic method ??????? Microspheres ??? microstreaming ????? Minitablet §³? Mixing ??? Mixtures ??? MLVs ????????? MMA ??????????? Moistening agent ????? Moisture absorption ????? Molecular capsules ?????? Multilamellar vesicles ??????? Multilayer tablets ???? Multiorfice-centrifugal process ???????? Myrij ?????????????? Myrj ???????????????? Nacent soap method ???????? Nanocapsule ?????? Nanocapsules ?????? Nanoemulsion ?????? Nanoemulsion ?????? Nanoliposomes ????????? Nanoparticles ?????? Nanosphere ?????? Nanospheres ?????? Naonparticle ?????? Nasal drops ?¦Á?? Newtonian equation ????????? Newtonian fluid ??????? Niosomes ??????ÈÉ???? Nonbound water ??????? Nonionic surfactant vesicles ????????????????? Non-newtonian flow ????????? Non-Newtonian fluid ????????? Nonprescription drug ?????? Noyes-Whitney???? ????????? NP -????? Nucleation theory ??????????? OCDDS ???????¦Ë????? OCDDS ??????(???)????? Ointments ????? Opitical isomerization ????? ORD ?????? Orthologonal design ??????? Osmotic pressure ???? OSSDDS ?????¦Ë????? Ostwald freundlich ???? ?????? Over the counter (OTC) ?????? Oversize distribution ????? PA ????? PACA ??????????????? Packing fraction ?????? Paints ??? Paints ???? Pan coating ?????¡¤? Paraffin ??? Particle size distribution ?????? Partition coefficient (P) ??????? Passive targeting preparation ??????????? Patch ???? PB ???? PBCA ???????????? PCS ?????????? PE ????? PE ????? Peel tack test ??????????? PEG ??????? PEG ??????? PEG ??????? PEG-EG PEG???¦Å??????????? Pendular state ???? Penetration enhancers ??????????? PEO ??????? PEO ??????? PEO ??????? Peregol O ?????????15??????? Perogol O ?????????15??????????? PET ????????????????? PG ?????? PGA ??????? Pharmaceutical engineering ???? Pharmaceutical manufacturing ??? Pharmaceutical preparation ?????? Pharmaceutics ???? Pharmacia ??????? Pharmacokinetics ?????? Pharmacological availability ???????? Pharmacopoeia ??? Phase inversion critical point ??????? Phase separation ?????????????????? Phase transition temperature ???????? Phase volume ratio ??? Phonophoresis ???????? Photodegradation ?????? PHPMA ?????????????? Physical and chemical T P ?????????????? Physical approach ????????? Physical pharmaceutics ???????? PIB ???????????? PiBCA ?????????????? PiBCA ????????????? PLA ?????? PLA ?????? PLA ?????? PLA/PGA, PLGA ??????????? PLA-PEG ??????????????¦É????? Plastic deformation ??????? Plastic viscosity ??????? Plastisity ???? PLGA ???????????????? PLGA ??????????????? PLGA ???????????????? PMMA ???????????? Poiseuile ??? ????????????? Poloxamer (plurnic) ?????????????????????? Poloxamer 188 (plurnic F68) ??????188?????????F68?? Poloxamer 188 (pluronic F68) ??????????????? Poloxamer 188 (Pluronic F68) ??????188?????????F68?? Poly (lactide-co-glycolide) ???????-????? POLYACRYLIC??RESIN ?????????? Polyalkylcyano-acrylate ?????????????? Polydiethylene terephthalate ????????????????? Polyethylene ????? Polyethylene (PEG) ??????? Polyethylene glycol PEG??????? Polyethylene glycol ??????? Polyethylene glycol (PEG) ??????? Polyethylene glycol (PEG) ??????? Polyethyleneglycol (PEG) ??????? Polymerization ??? Polymers in pharmaceutics ??????????? Polymethyl methacrylate ???????????? Polymorphism ???? Polymorphism ???? Polyoxyethylene ??????? Polyoxyl 40 stearate (Myri52) S-40?????????40?????????? Polypropylene ???? Polysorbate ??????? Polyvinyl alcohol ??????? Polyvinyl alcohol (PVA) ??????? Polyvinyl chloride ??????? Polyvinylpyrrolidine PVP???? Polyvinylpyrrolidone ???? Porosity ????? Porosity ????? Povidone ??????????? Powder injection ?????¦Ä????? Powders ??? PP ???? PP ???? Preformulation ????????? Pregelatinized starch ????????????????????????? Preservative ?????? Pressure sensitive adhersive ????? Pressure-sensitive tape council ??????? Prickle cell layer ???? Primary particle ??????? Prodrug ?????? propellents ????? Propylene glycol ?????? Propylene glycol (PG) ?????? PS(phosphatidylserine) ?????????? PSA ????? Pseudo steady state ¦Á??? Pseudoplastic flow ?????????? PSTC ??????? Pulsed/pulsatile release ??????? PVA ??????? PVA ??????? PVAP ????? PVC ??????? PVC ??????? PVC ??????? PVP ???? PVP ???? PVP ???? PVP (PVPk15, PVPk30, PVPk90) ???? PVPP ??????????????? PVPP??????PVP?? ???????? Pycnometer ????? Pyrogen ??? QOL ???????? Quasi-viscous flow ????????? Racemization ???????????? Raman ???? Random floc ???????????? Raoult???? ????????? rapid expansion of supercritical S RESS Rate of shear ????????????????????? Receptor cell ????? Relative humidity RH?????? Relative humidity (RH) ?????? Response surface methodology §¹???????? RESS ??????????????????? Retardants ????? Reverse osmosis ????? Rheology ????? Rittinger?? ????÷Ï??????? Rolling ball tack test ???????? RP-HPLC ?????§¹???????? Rubbing ????? Rumpf ??????????? SA ?????? Safety ????? Safflower ????? SDB-L-400 ???????????? SDS, SLS ???????????? SDS-PAGE SDC?????????????? SEC ????????????? Second particle ???????? SEDDSs ???÷ö??????? Sedimentation method ?????? Sedimentation rate ????????? Self-adjusted system ????????? SEM ???Á‚ Sensitization ???????? Settling velocity diameter ??§¹?? SFDA SFDA Shape factor ?????? Shear mixing ???§Ý?? Shearing force ????????????????????? Sieving diameter Da?????? Sieving method ???? Sieving method ???? Simple coacervation ??????? Simplex method ??????????? Single unilamellar vesicles §³????????? Sink condition ??? Sink condition ????? Size exclusion chromatography SEC Slurry state ??? Sodium carboxymethyl starch ?????????? Sodium lauryl sulfate (SDS) ???????????? Sodium taurodihydrofusidate ???????¨´???? Soft capsules ??????? Soft paraffin ????? Solid bridges ?????????? Solid lipid nanospheres (SLN) ????????????? Solubility ???? Solubility parameter ??????? Solubilization ???? Solubilization ???? Solubilization ???? Solubilizer ????? Solubilizer ????? Solution tablets ???? Solutions ????? Solvent-nonsolvent ???????????? SOP ?????????? Soybean-derived sterol ????? Span ??? Span ????ÍÝ??????? Span 80 ???????? Specific acid-base catalysis ???????? Specific surface area ?????? Specific surface area method ???????? Specific volume ???? Spermaceti ???? Spirits ???? Spongia, spongc ????? Spray congealing ???????? Spray drying ???????? SS ?????? Stability ????? Starch ???? Starch glycolate (CMS-Na) ?????????? state food and drug administration SFDA STDHF ???????????? Sterility ??? Sterilization ??? Sticky powder ?????? Stocks diameter Stocks?? Stokes ???? ??????? Stratum granulosum ???? Stratum lucidum ????? Stress ????? Stress relaxation ??????? Stress testing ??????????î”??????? Striping of stratum corneum ???????? Subcutaneous (SC) route ?????? Sublingual tablets ????? Subnanoemulsion ???????? Sugar ??? Sugar coated tablets ????? Supercritical Fluid (SCF) ????????‰Í????? Suppositories ??? Surelease ?????????????? Surface basis ?????? Suspending agents ?????? Suspensions ?????? Sustained release tablets ????? Sustained-release preparation ??????? SUVs §³????????? Synergists §¿??? synthesis of bioconvertible Prod ???????????????? Synthesis of lipophilic analogs ???????????? Synthesis of prodrugs ????????? Syrups ????? Tablets ??? Tacking strength ????? Talc ????? Tap density ?????? Targeting drug system (TDS) ???????? TDDS ????????? TDDS ?????????? TDDS ????????? TEM ???Á‚ TEM ???Á‚ Tensile strength (Ts) ??????? The technique of sterilization ??????? Theory of depletion stabilization ?????????? Thermal energy ????????? Thixlotropy ?????? Thumb tack test ????? Time clock ????? Time controlled explosive system ???-????? Tincture ???? Tincture ???? Titer ????¦Æ? Topochemical reactions ????????? Toroches ???? Transdermal therapeutic system ??????? Transfersome ?????? True density ????? TTS ?????????? Tween ???????????ÍÝ??????? Under distribution ??¡¤?? Uniform design ??????? Uppsala ??????? UV ???? Vaginal tablets ????? Vander walls ?? ??????? Vaselin ????? Vertebra caval route ??????? viscoelasticity ????? Viscosity ??? Viscosity ??? Viscosity coefficient ?????? Viscosity curve ??????? Void ratio ????? Volume basis ?????? Wagner-Nelson???? ?????-????????? Watch glass method ??????????????ï‚ Water ? Wet bulb temperature ?????? Wet granulation ??????? Wetting ????? Wool fat ???? Wool fat anhydrous ??????? Yield value ????? ??-CYD ?????????? ????????OT ????????????????? ????CMC-Na ??????????????? ??????SG ????????????? ?÷ö??OP ?????????20??????? ?÷ö??SE-10 |
2Â¥2006-04-13 09:11:39
³¬¼¶µ¾²ÝÈË
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 342.8
- Ìû×Ó: 426
- ÔÚÏß:
- ³æºÅ: 186570
- ×¢²á: 2006-02-16
- ÐÔ±ð: MM
- רҵ: ҩѧ
3Â¥2006-04-13 09:14:35
4Â¥2006-04-13 10:21:58
0.5
![]() ![]() |
5Â¥2006-04-13 10:27:56
0.5
| ¶¥¡£ |
6Â¥2006-04-13 10:40:42
7Â¥2006-04-14 16:30:06
0.5
| 3q |
8Â¥2006-04-14 16:50:49
lingboo
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 838.4
- Ìû×Ó: 60
- ÔÚÏß: 18.2Сʱ
- ³æºÅ: 162299
- ×¢²á: 2006-01-10
- רҵ: Ò©ÀíѧÆäËû¿ÆÑ§ÎÊÌâ
9Â¥2006-04-14 17:39:57
0.5
10Â¥2006-04-23 21:22:31














»Ø¸´´ËÂ¥

